Last Tuesday, February 27, 2018, representatives of CVS Health and Aetna went before the House Judiciary Committee Subcommittee on Regulatory Reform, Commercial, and Antitrust Law (“Subcommittee”) to argue in favor of CVS...more
3/7/2018
/ Acquisitions ,
Aetna ,
Anti-Competitive ,
Antitrust Provisions ,
Centers for Medicare & Medicaid Services (CMS) ,
CVS ,
Health Insurance ,
Healthcare Costs ,
Pharmaceutical Industry ,
Pharmacies ,
Regulatory Reform ,
Supply Chain